AU Patent

AU2014289312A1 — Benzyl-1H-pyrazolo(3,4-b)pyridines and use thereof

Assigned to Bayer Pharma AG · Expires 2016-02-11 · 10y expired

What this patent protects

The invention relates to novel benzyl-1H-pyrazolo[3,4-b]pyridines, to methods for the production thereof, to the use thereof alone or in combination for the treatment and/or prophylaxis of diseases, and to the use thereof for producing medicaments for the treatment and/or prophyl…

USPTO Abstract

The invention relates to novel benzyl-1H-pyrazolo[3,4-b]pyridines, to methods for the production thereof, to the use thereof alone or in combination for the treatment and/or prophylaxis of diseases, and to the use thereof for producing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of cardiovascular disorders.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014289312A1
Jurisdiction
AU
Classification
—
Expires
2016-02-11
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.